Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleolar protein with MIF4G domain 1 (NOM1) is a nucleolar protein containing MIF4G and/or MA3 domains, involved in RNA processing and pre-rRNA maturation by interacting with DEAD-box RNA helicases and functioning as a scaffold for ribosome biogenesis. NOM1 also acts as a regulatory subunit for protein phosphatase 1 (PP1), mediating PP1 recruitment to the nucleolus via a conserved RVXF motif and nucleolar localization sequence. In addition, NOM1 is implicated in signaling pathways with the insulin-like growth factor 1 receptor (IGF1R) and participates in the regulation of cell growth, proliferation, and nucleolar function. NOM1 is not currently considered a direct therapeutic drug target nor are there any approved drugs or established biomarkers directly targeting this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleolar protein with MIF4G domain 1 (NOM1).